Opposite effects of WEB2086 on angiogenesis in atheromas and ischemic hindlimb of apoE gene deficient mice

Chinese Medical Journal

Volumn 120, Issue 10, 2007, Pages 886-892

  Wang, Shuang ^a,b   Tang, Ya Ling ^b   Yang, Yong Zong ^b   Xu, Zeng Xiang ^b   Peng, Kuang ^b  

^a Central South University   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Angiogenesis; Atheroma; Ischemic hindlimb; PAF receptors

Indexed keywords

APAFANT; APOLIPOPROTEIN E; CD31 ANTIGEN; CHOLESTEROL; DRINKING WATER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; THROMBOCYTE ACTIVATING FACTOR; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; AORTA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAPILLARY DENSITY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DOPPLER FLOWMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROCNEMIUS MUSCLE; IMMUNOHISTOCHEMISTRY; LIMB BLOOD FLOW; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE LEVEL; TISSUE SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 34249802307     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200705020-00007     Document Type: Article

References (25)

1. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999; 99: 1726-1732.
2. Subbanagounder G, Leitinger N, Shih PT, Faull KF, Berliner JA. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis - in vitro and in vivo inhibition by WEB2086. Circ Res 1999; 85: 311-318.
3. Montrucchio G, Alloatti G, Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 2000; 80: 1669-1699.
4. Lupia E, Pucci A, Peasso P, Merlo M, Baron P, Zanini C, et al. Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions. Int J Mol Med 2003; 12: 327-334.
5. Chang PY, Luo S, Jiang T, Lee YT, Lu SC, Henry PD, et al. Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through pertussis toxin-sensitive G-protein pathway mediator role of platelet-activating factor-like phospholipids. Circulation 2001; 104: 588-593.
6. Couffinhal T, Silver M, Kearney M, Sullivan A, Witzenbichler B, Magner M, et al. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in apoE gene deficient mice. Circulation 1999; 99: 3188-3198.
7. Zhang X, Yuan CL, Zhang HZ, Huang RX. Age-related increase of plasma platelet-activating factor concentrations in Chinese. Clin Chim Acta 2003; 337: 157-162.
8. Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, et al. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler Thromb Vasc Biol 2002; 22: 1649-1654.
9. Chen YX, Nakashima Y, Tanaka K, Shiraishi S, Nakagawa K, Sueishi K. Immunohistochemical expression of vascular endothelial growth factor/ vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler Thromb Vasc Biol 1999; 19:131-139.
10. Kruger EA, Figg WD. Protein binding alters the activity of suramin, carboxyamidotriazole, and UCN-01 in an ex vivo rat aortic ring angiogenesis assay. Clin Cancer Res 2001; 7: 1867-1872.
11. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003; 100: 4736-4741.
12. Ma X, Ottino P, Bazan HE, Bazan NG. Platelet-activating factor (PAF) induces corneal neovascularization and up regulates VEGF expression in endothelial cells. Invest Ophthalmol Vis Sci 2004; 45: 2915-2921.
13. Frostegard J, Huang YH, Ronnelid J, Schafer-Elinder L. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism. Arterioscler Thromb Vasc Biol 1997; 17: 963-968.
14. Russo S, Bussolati B, Deambrosis I, Mariano F, Camussi G Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction. J Immunol 2003; 171: 5489-5497.
15. Bussolati B, Biancone L, Cassoni P, Russo S, Rola-Pleszczynski M, Montrucchio G, et al. PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis. Am J Pathol 2000; 157: 1713-1725.
16. Montrucchio G, Lupia E, Battaglia E, Del Sorbo L, Boccellino M, Biancone L, et al. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Arterioscler Thromb Vasc Biol 2000; 20: 80-88.
17. Camussi G, Montrucchio G, Lupia E, Soldi R, Comoglio PM, Bussolino F. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. J Immunol 1997; 158: 1302-1309.
18. Subbanna PK, Tyagi MG. PAF antagonism modifies neuroprotective action of histone deacetylase and calcineurin phosphatase inhibitors in mice. Indian J Exp Biol 2006; 44: 886-891
19. Camussi G, Montrucchio G, Lupia E, De Martino A, Perona L, Arese M, et al. Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J Immunol 1995; 154: 6492-6501.
20. Wei LX, Tang QH, Sun L, Shi HY, Guo AT, You LB. Relationship between oxidized lipoprotein, angiogenesis and human coronary atherosclerotic plaque stabilization. Chin J Pathol (Chin) 2006; 35: 138-141.
21. Chen CH, Cartwright J Jr, Li Z, Lou S, Nguyen HH, Gotto AM Jr, et al. Inhibitory effects of hypercholesterolemia and ox-LDL on angiogenesis-like endothelial growth in rabbit aortic explants. Essential role of basic fibroblast growth factor. Arterioscler Thromb Vasc Biol 1997; 17: 1303-1312.
22. Stengel D, Antonucci M, Arborati M, Hourton D, Griglio S, Chapman MJ, et al. Expression of the PAF receptor in human monocyte-derived macrophages is downregulated by oxidized LDL relevance to the inflammatory phase of atherogenesis. Arterioscler Thromb Vasc Biol 1997; 17: 954-962.
23. Lehr HA, Seemuller J, Hubner C, Menger MD, Messmer K. Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet-activating factor. Arterioscler Thromb 1993; 13: 1013-1018.
24. Chen CH, Jiang W, Via DP, Luo S, Li TR, Lee YT, et al. Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation 2000; 101: 171-177.
25. Doi K, Okamoto K, Negishi K, Suzuki Y, Nakao A, Fujita T, et al. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am J Pathol 2006; 168: 1413-1424.